Lexology December 10, 2025
The intensity of China’s transformation over the past decades has unleashed unparalleled momentum while also presenting profound challenges to its socioeconomic ambitions, impacting how multinationals navigate this new environment. Nowhere is this tension more critical than in its health system, where building a more prosperous society hinges on reducing stark health disparities that have constrained China for decades. The Healthy China 2030 initiative, launched in 2016, was designed to resolve this tension, and in the process has opened massive market opportunities across the healthcare, pharmaceutical, and technology sectors. But, with the 2030 deadline rapidly approaching, progress toward its goals remains uneven and complex, necessitating careful planning and foresight by companies pursuing success in China’s health economy. In the below piece,...
Today's Sponsors
Today's Sponsor